129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT06104228 · RECRUITING

Trial details

NCT number: NCT06104228
Sponsor: Bastiaan Driehuys
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension Idiopathic Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)Connective Tissue Diseases

Start date: 2024-08-12
Primary completion: 2027-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.